On September 3, 2024, Johanna Roberts, Executive Vice President, General Counsel & Secretary of Penumbra Inc (PEN, Financial), sold 600 shares of the company. The transaction was documented in an SEC Filing. Following this sale, the insider now owns 61,088 shares of Penumbra Inc.
Penumbra Inc, a healthcare company, is primarily engaged in the design, development, manufacture, and marketing of innovative medical devices. The company focuses on developing products to treat peripheral vascular and neurovascular diseases.
Over the past year, Johanna Roberts has sold a total of 6,000 shares and has not purchased any shares. This recent sale is part of a broader trend observed within the company, where there have been 26 insider sells and no insider buys over the past year.
Shares of Penumbra Inc were trading at $206.22 on the day of the sale. The company has a market cap of approximately $7.93 billion. The price-earnings ratio of Penumbra Inc stands at 595.74, significantly higher than both the industry median of 27.51 and the company's historical median.
The GF Value of Penumbra Inc is estimated at $295.90, suggesting that the stock is significantly undervalued with a price-to-GF-Value ratio of 0.7. The GF Value is calculated based on historical trading multiples, a GuruFocus adjustment factor, and future business performance estimates from analysts.
This insider sale might interest investors tracking insider behaviors as an indicator of confidence levels concerning the company's current valuation and future prospects.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
